Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Psychiatr Serv. 2019 May 21;70(8):650–656. doi: 10.1176/appi.ps.201800504

Table 3. Hazard Ratios for polypharmacy from the base case analysis.

Unplanned admissions Death ED presentations
HR 95% CI HR 95% CI HR 95% CI
Polypharmacy 1.14 (.98–1.32) 1.02 (.76–1.37)  .95 (.80–1.14)
No antipsychotic substance     1.08** (1.03–1.14) 1.02 (.94–1.10)     1.19*** (1.14–1.24)
**

p<0.01

***

p<0.001; 95% CI in parentheses